| 000 | 03318nam a22006255i 4500 | ||
|---|---|---|---|
| 001 | 978-3-319-45826-7 | ||
| 003 | DE-He213 | ||
| 005 | 20210118143030.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 161123s2017 gw | s |||| 0|eng d | ||
| 020 |
_a9783319458267 _9978-3-319-45826-7 |
||
| 024 | 7 |
_a10.1007/978-3-319-45826-7 _2doi |
|
| 050 | 4 | _aT174.7 | |
| 050 | 4 | _aTA418.9.N35 | |
| 072 | 7 |
_aTBN _2bicssc |
|
| 072 | 7 |
_aTEC027000 _2bisacsh |
|
| 072 | 7 |
_aTBN _2thema |
|
| 082 | 0 | 4 |
_a620.115 _223 |
| 100 | 1 |
_aKumar, Piyush. _eauthor. _4aut _4http://id.loc.gov/vocabulary/relators/aut |
|
| 245 | 1 | 0 |
_aNanomedicine for Cancer Therapy _h[electronic resource] : _bFrom Chemotherapeutic to Hyperthermia-Based Therapy / _cby Piyush Kumar, Rohit Srivastava. |
| 250 | _a1st ed. 2017. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2017. |
|
| 300 |
_aVIII, 68 p. 17 illus., 2 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aNanotheranostics, _x2197-6740 |
|
| 520 | _aThis Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the nanoparticle approach. . | ||
| 650 | 0 | _aNanotechnology. | |
| 650 | 0 | _aCancer research. | |
| 650 | 0 | _aBiomedical engineering. | |
| 650 | 0 | _aRegenerative medicine. | |
| 650 | 0 | _aTissue engineering. | |
| 650 | 1 | 4 |
_aNanotechnology. _0http://scigraph.springernature.com/things/product-market-codes/Z14000 |
| 650 | 2 | 4 |
_aCancer Research. _0http://scigraph.springernature.com/things/product-market-codes/B11001 |
| 650 | 2 | 4 |
_aBiomedical Engineering and Bioengineering. _0http://scigraph.springernature.com/things/product-market-codes/T2700X |
| 650 | 2 | 4 |
_aRegenerative Medicine/Tissue Engineering. _0http://scigraph.springernature.com/things/product-market-codes/L16080 |
| 700 | 1 |
_aSrivastava, Rohit. _eauthor. _4aut _4http://id.loc.gov/vocabulary/relators/aut |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783319458250 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783319458274 |
| 830 | 0 |
_aNanotheranostics, _x2197-6740 |
|
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-3-319-45826-7 |
| 912 | _aZDB-2-ENG | ||
| 999 |
_c450959 _d450959 |
||
| 942 | _cEB | ||
| 506 | _aAvailable to subscribing member institutions only. Доступно лише організаціям членам підписки. | ||
| 506 | _fOnline access from local network of NaUOA. | ||
| 506 | _fOnline access with authorization at https://link.springer.com/ | ||
| 506 | _fОнлайн-доступ з локальної мережі НаУОА. | ||
| 506 | _fОнлайн доступ з авторизацією на https://link.springer.com/ | ||